Aldeyra Therapeutics, Inc. (ALDX)
0.68
-0.02
(-2.87%)
USD |
NASDAQ |
Oct 19, 14:45
Aldeyra Therapeutics Cash from Operations (Annual) : -33.35M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -33.35M |
| December 31, 2024 | -43.21M |
| December 31, 2023 | -30.33M |
| December 31, 2022 | -56.64M |
| December 31, 2021 | -42.56M |
| December 31, 2020 | -37.49M |
| December 31, 2019 | -44.98M |
| December 31, 2018 | -29.86M |
| Date | Value |
|---|---|
| December 31, 2017 | -19.39M |
| December 31, 2016 | -15.15M |
| December 31, 2015 | -9.348M |
| December 31, 2014 | -4.776M |
| December 31, 2013 | -1.707M |
| December 31, 2012 | -0.778M |
| December 31, 2011 | -2.393M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Prime Medicine, Inc. | -162.56M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |
| Sarepta Therapeutics, Inc. | -222.54M |